Evercore ISI Group Initiates Coverage On Tenax Therapeutics with Outperform Rating, Announces Price Target of $39

Benzinga Newsdesk www.benzinga.com Positive 81.6%

Neg 0% Neu 0% Pos 81.6%

Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Outperform rating and announces Price Target of $39.